MERZ PHARMACEUTICALS GMBH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1908-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.radiesse.de
Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
- Conditions
- Cerebral PalsySpasticity
- Interventions
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 351
- Registration Number
- NCT02002884
- Locations
- 🇺🇸
Merz Investigational Site #001186, Chicago, Illinois, United States
🇺🇸Merz Investigational Site No. #001302, Royal Oak, Michigan, United States
🇲🇽Merz Investigational Site #052024, Mexico City, Mexico
Effectiveness and Safety Study of Overnight Intensive Patch in Scars
- Conditions
- Post Dermatological Surgery Scars
- Interventions
- Device: Overnight Intensive Patch
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 125
- Registration Number
- NCT01910896
- Locations
- 🇩🇪
Merz Investigational Site # 0490341, Augsburg, Germany
🇩🇪Merz Investigational Site # 0490312, Berlin, Germany
🇩🇪Merz Investigational Site # 049307, Hamburg, Germany
Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
- Conditions
- Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy
- Interventions
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 370
- Registration Number
- NCT01905683
- Locations
- 🇷🇺
Merz Investigational Site #007014, Kazan, Russian Federation
🇵🇱Merz Investigational Site #048072, Lubon, Poland
🇷🇴Merz Investigational Site #040003, Bucharest, Romania
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
- Conditions
- Female Pattern Hair LossAndrogenetic Alopecia (AGA)Ludwig Type 1Ludwig Type 2
- Interventions
- Drug: PantovigarDrug: Minoxidil 2% only
- First Posted Date
- 2013-07-16
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 74
- Registration Number
- NCT01900041
- Locations
- 🇷🇺
Moscow Scientific Clinical Center of Dermatology and Cosmetology, Moscow, Russian Federation
🇷🇺State Scientific Center of Dermatology and Cosmetology, Moscow, Russian Federation
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
- Conditions
- Bilateral Blepharospasm (BEB)
- Interventions
- Drug: IncobotulinumtoxinA (Xeomin), 12.5 UnitsDrug: IncobulinumtoxinA (Xeomin), 25 UnitsDrug: PlaceboDrug: IncobotulinumtoxinA (Xeomin), 35 Units
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 61
- Registration Number
- NCT01896895
- Locations
- 🇱🇰
Merz Investigational Site #094001, Colombo, Sri Lanka
🇱🇰Merz Investigational Site #094006, Kurunegala, Sri Lanka
🇬🇷Merz Investigational Site #030002, Athens, Greece
Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
- Conditions
- Lower Limb Spasticity Due to Cerebral Palsy
- Interventions
- First Posted Date
- 2013-07-09
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 311
- Registration Number
- NCT01893411
- Locations
- 🇮🇱
Merz Investigational Site #972001, Tel Aviv, Israel
🇵🇱Merz Investigational Site #048059, Kraków, Poland
🇷🇺Merz Investigational Site #007015, Khabarovsk, Russian Federation
Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
- Conditions
- Healthy Volunteers and Glaucoma Patients
- Interventions
- Drug: MRZ-99030 eye drops 5mg/mLDrug: MRZ-99030 eye drops 20mg/mLDrug: Placebo to MRZ-99030 eye drops
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2014-01-29
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 70
- Registration Number
- NCT01714960
- Locations
- 🇩🇪
Parexel International GmbH, Early Phase Clinical Unit, Berlin, Germany
Blepharospasm Patient Survey for Patients With Blepharospasm
- Conditions
- Blepharospasm
- Interventions
- Other: No intervention- only one time survey
- First Posted Date
- 2012-09-17
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 124
- Registration Number
- NCT01686061
- Locations
- 🇺🇸
Merz Investigative Site #0007, Fountain Valley, California, United States
🇺🇸Merz Investigative Site # 0002, Sarasota, Florida, United States
🇺🇸Merz Investigative Site # 0006, Columbus, Ohio, United States
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
- Conditions
- Spasticity of the Upper and Lower Limb Due to Cerebral Causes
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 155
- Registration Number
- NCT01603459
- Locations
- 🇳🇴
Merz Investigational Site #047001, Bergen, Norway
🇵🇹Merz Investigational Site # 351001, Lisboa, Portugal
🇺🇸Merz Investigational Site # 001197, Doral, Florida, United States
Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
- Conditions
- Habitual Snoring
- Interventions
- Drug: Placebo ComparatorDrug: IncobotulinumtoxinA
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Target Recruit Count
- 8
- Registration Number
- NCT01515371
- Locations
- 🇩🇪
Merz Investigational Site #049294, Regensburg, Germany